Number of the records: 1  

Phenolic and flavonoid production and antimicrobial activity of Gymnosporia buxifolia (L.) Szyszyl cell cultures

  1. 1.
    0497003 - ÚEB 2019 RIV NL eng J - Journal Article
    Kumari, A. - Naidoo, D. - Baskaran, P. - Doležal, Karel - Nisler, Jaroslav - Van Staden, J.
    Phenolic and flavonoid production and antimicrobial activity of Gymnosporia buxifolia (L.) Szyszyl cell cultures.
    Plant Growth Regulation. Roč. 86, č. 3 (2018), s. 333-338. ISSN 0167-6903. E-ISSN 1573-5087
    R&D Projects: GA MŠMT(CZ) LO1204
    Institutional support: RVO:61389030
    Keywords : Antibacterial activity * Biomass * Medicinal plant * Phenolic content * Plant cell culture
    OECD category: Plant sciences, botany
    Impact factor: 2.473, year: 2018

    Gymnosporia buxifolia (Celastraceae) is a well-known traditional medicinal plant used to treat various diseases. The aim of the study was to quantify the total phenolic and flavonoid content of cell biomass of G. buxifolia developed in vitro using plant growth regulators (PGRs), phloroglucinol (PG) and an antagonist of cytokinin activity 6-(2-hydroxy-3-methylbenzylamino) purine (PI55). The antibacterial activity of calli was also evaluated. The accumulation of phenolic contents and its antibacterial activity in the cell biomass varied between the treatments as well as the mother plant. Generally, a higher accumulation of phenolic contents translated to improved activity against selected pathogenic bacteria. This was apparent in biomass derived from solid and liquid MS media containing combinations of 5 µM PG, 1.5 µM benzyladenine (BA) or meta-topolin (mT) with or without 1 µM picloram (Pic) and 5 µM PG or PI55, 1 µM BA with or without 0.5 µM Pic respectively. The choice of PGRs, PG and PI55 treatments used during in vitro cell culture systems influenced the therapeutic potential of G. buxifolia. Our results indicate that the cell biomass from suspension and/or solid culture of G. buxifolia could be promising as antibacterial agents with possible applications in the pharmaceutical industry.
    Permanent Link: http://hdl.handle.net/11104/0289615

     
    FileDownloadSizeCommentaryVersionAccess
    2018_Kumari_PLANT GROWTH REGULATION_333.pdf4838.1 KBOtheropen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.